Intracranial Hypertension and Optic Nerve Sheath Diameter "DENO"


Phase N/A Results N/A

Summary of Purpose

Intracranial hypertension (ICH) is a mortality risk factor in severe traumatic brain injury (TBI), in purulent meningitis, in hepatic encephalopathy and in Reye's syndrome. It is also a risk factor for severe neurologic sequelae in survivors. Intracranial pressure (ICP) monitoring is likely to guide therapeutics, and certain research on adults or on children, suggest that IH therapeutic approach, for instance for...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 August 2016.

1 Apr 2011 25 Oct 2012 1 Jan 2017 1 Jun 2017 1 Aug 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Diagnostic
  • Endpoint: Efficacy Study
  • Intervention: Single Group Assignment


  • Etienne JAVOUHEY, professor